Phase I study of CT-2103 [paclitaxel poliglumex] and radiotherapy for locally advanced, unresectable non-small cell lung cancer
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2005
At a glance
- Drugs Paclitaxel poliglumex (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 07 Dec 2005 New trial record.